急性髓系白血病中化学免疫疗法与化学疗法的比较。初步结果。
Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.
作者信息
Fiere D, Doillon M, Martin C, Vu Van T, Revol L
出版信息
Biomedicine. 1976 Dec 5;25(9):318.
PMID:1069595
Abstract
Since November 1974, 44 patients with acute myeloid leukemia, in first remission were randomized between chemotherapy alone and chemotherapy plus BCG. There were 8 relapses and 7 deaths with chemotherapy, 7 relapses and 3 deaths with chemotherapy plus BCG. The survival of both groups is not, at the time, significantly different.
摘要
自1974年11月起，44例处于首次缓解期的急性髓系白血病患者被随机分为单纯化疗组和化疗加卡介苗组。单纯化疗组有8例复发、7例死亡，化疗加卡介苗组有7例复发、3例死亡。目前，两组的生存率无显著差异。
Zotero 插件